Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorder
ADR ID BADD_A05828
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.04      Lipid metabolism and deposit disorders NEC
14.08.04.003      Lipid metabolism disorder
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10061227
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Disorders of lipoid metabolism | Fat disorder | Lipid metabolism disorder NOS | Other disorders of lipoid metabolism | Unspecified disorder of lipoid metabolism | Unspecified disorders of lipoid metabolism | Lipidosis acquired | Lipid metabolism disorder | Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00142Anastrozole--
BADD_D00260Betamethasone--
BADD_D00623Dexamethasone--
BADD_D00898Finasteride0.000099%
BADD_D01022Gliclazide--
BADD_D01091Hydrocortisone sodium succinate--
BADD_D01260Leuprolide acetate0.001434%
BADD_D01434Methylprednisolone acetate--
BADD_D01436Methylprednisolone sodium succinate--
BADD_D01832Prednisolone acetate--
BADD_D01834Prednisone--
BADD_D01915Ranolazine0.000427%
BADD_D02272Triamcinolone acetonide--
BADD_D02436Atorvastatin--
BADD_D02539Calcium0.000391%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target